Key indicators: single-crystal X-ray study; T = 193 K; mean (C-C) = 0.006 Å; disorder in solvent or counterion; R factor = 0.062; wR factor = 0.150; data-toparameter ratio = 17.0.
In the title compound, C 18 H 24 N 6 OÁH 2 O, the piperidine ring adopts a chair conformation with an N-C-C-C torsion angle of 39.5 (5) between the cis-related substituents. The pyrrole N-H group forms a water-mediated intermolecular hydrogen bond to one of the N atoms of the annelated pyrimidine ring. The water molecule connects two organic molecules and is disorderd over two positions (occupancies of 0.48 and 0.52). The crystal packing shows zigzag chains of alternating organic and water molecules running parallel to the a axis.
Related literature
For the biological activity and structure-activity relationships of tofacitinib {systematic name: 3- [(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d] pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile} derivatives, see : Flanagan et al. (2010) . For a general overview on the JAK-STAT pathway, see: Shuai & Liu (2003) . The use of oxetanes as carbonyl bioisosteres has been reviewed extensively by Wuitschik et al. (2010) . For a recent application of this concept towards tofacitinib-derived JAK3 inhibitors, see : Gehringer et al. (2014) .
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Shuai & Liu, 2003) . Recently, Tofacitinib (CP690, 550; pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile) a small-molecule pan-JAK inhibitor was approved by the US Food and Drug Administration for the treatment of rheumatoid athritis (Flanagan et al., 2010) . The compound also shows promising results in late stage clinical trials for psoriasis, transplant rejection, and other disorders of the immune system. In search for novel JAK inhibitors, the title compound was prepared as a Tofacitinib bioisostere with altered physicochemical properties (Wuitschik et al., 2010) .
In the crystal structure of the title compound, C 18 H 24 N 6 O, the exocyclic amino substituent is oriented almost coplanar to the heteroaromatic ring system with a torsion angle of 0.6 (2)° for C11-N10-C5-C4. The piperidine ring adopts a chair conformation with a torsion angle of 39.5 (5) ° between the cis substituents. One of the protons (H23B) of the methylene group between the oxetane ring and the nitrile function is involved in an intermolecular C-H···π interaction while the other methylene proton forms an intermolecular C-H···N interaction with the nitrile group. The oxygen atom of the oxetane ring makes two intermolecular C-H···O contacts with two H atoms (H13A and H15B) of the piperidine ring. 
In an (3R, 4R) 
and (oxetan-3-ylidene)acetonitrile (19.9 mg, 210 µmol) were dissolved in dry ethanol (400 µl) and the mixture stirred at 323 K during 48 h. The solvent was evaporated under reduced pressure and the product purified by column chromatography (SiO 2 , ethyl acetate + 2% methanol). The product was obtained as off-white solid (57.0 mg, 82%).
Crystals of the title compound were obtained by slow evaporation of a solution in chloroform + 10% methanol at 298 K.
Refinement
Site occupation factors of the disordered water molecule were fixed assuming similar isotropic displacement parameters with C-H = 0.95 Å (aromatic) or 0.99-1.00 Å (sp 3 C-atom). All H atoms were refined with isotropic displacement parameters (set at 1.2-1.5 times of the U eq of the parent atom). One of the H atoms of the disordered water molecule could be position to make a hydrogen bond to an N atom. The other one was positioneded with idealized geometric with respect to the first one. The absolute configuration was assigned according to the synthesis.
Figure 1
Crystal structure of the title compound with labeling and displacement ellipsoids drawn at the 50% probability level.
Water molecules are disorderd with s.o.f. 0.52/0.48. Symmetry codes: (i) x+1/2, −y+1/2, −z+1; (ii) −x+1/2, −y+1, z+1/2.
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